Statement on the safety of EstroG-100 as a novel food pursuant to Regulation (EC) No 258/97.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Turck D, Bresson JL, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle HJ, Naska A, Neuhäuser-Berthold M, Nowicka G, Pentieva K, Sanz Y, Siani A, Sjödin A, Stern M, Tomé D, Vinceti M, Willatts P, Engel KH, Marchelli R, Pöting A, Poulsen M, Schlatter JR, Turla E, van Loveren H.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
EFSA J. 2017 May 8;15(5):e04778. doi: 10.2903/j.efsa.2017.4778. eCollection 2017 May.
EFSA J. 2017.
PMID: 32625484
Free PMC article.
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to update its scientific opinion on the safety of EstroG-100 as a novel food (NF) in the light of additional information submitted by the applican …
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to update its …